Cite
HARVARD Citation
Rahaghi, F. et al. (2021). Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib. Clinical medicine insights. p. . [Online].